Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Diagnostic Potential of Supplemental Static and Dynamic 68Ga-FAPI-46 PET for Primary 18F-FDG-Negative Pulmonary Lesions.
J Nucl Med. 2024 Apr 11:jnumed.123.267103. doi: 10.2967/jnumed.123.267103. Online ahead of print.
J Nucl Med. 2024.
PMID: 38604763
FAPI-74 PET/CT Using Either 18F-AlF or Cold-Kit 68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients.
Giesel FL, Adeberg S, Syed M, Lindner T, Jiménez-Franco LD, Mavriopoulou E, Staudinger F, Tonndorf-Martini E, Regnery S, Rieken S, El Shafie R, Röhrich M, Flechsig P, Kluge A, Altmann A, Debus J, Haberkorn U, Kratochwil C.
Giesel FL, et al. Among authors: mavriopoulou e.
J Nucl Med. 2021 Feb;62(2):201-207. doi: 10.2967/jnumed.120.245084. Epub 2020 Jun 26.
J Nucl Med. 2021.
PMID: 32591493
Free PMC article.
Item in Clipboard
Response Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase.
Rathke H, Holland-Letz T, Mier W, Flechsig P, Mavriopoulou E, Röhrich M, Kopka K, Hohenfellner M, Giesel FL, Haberkorn U, Kratochwil C.
Rathke H, et al. Among authors: mavriopoulou e.
J Nucl Med. 2020 May;61(5):689-695. doi: 10.2967/jnumed.119.231431. Epub 2019 Oct 25.
J Nucl Med. 2020.
PMID: 31653712
Free article.
Item in Clipboard
Dosimetry Estimate and Initial Clinical Experience with 90Y-PSMA-617.
Rathke H, Flechsig P, Mier W, Bronzel M, Mavriopoulou E, Hohenfellner M, Giesel FL, Haberkorn U, Kratochwil C.
Rathke H, et al. Among authors: mavriopoulou e.
J Nucl Med. 2019 Jun;60(6):806-811. doi: 10.2967/jnumed.118.218917. Epub 2018 Nov 2.
J Nucl Med. 2019.
PMID: 30389816
Free article.
Item in Clipboard
Whole body bone SPET/CT can successfully replace the conventional bone scan in breast cancer patients. A prospective study of 257 patients.
Mavriopoulou E, Zampakis P, Smpiliri E, Spyridonidis T, Rapti E, Haberkorn U, Makatsoris T, Apostolopoulos DJ.
Mavriopoulou E, et al.
Hell J Nucl Med. 2018 May-Aug;21(2):125-133.
Hell J Nucl Med. 2018.
PMID: 30089314
Free article.
Clinical Trial.
Item in Clipboard
SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors.
Kratochwil C, Stefanova M, Mavriopoulou E, Holland-Letz T, Dimitrakopoulou-Strauss A, Afshar-Oromieh A, Mier W, Haberkorn U, Giesel FL.
Kratochwil C, et al. Among authors: mavriopoulou e.
Mol Imaging Biol. 2015 Jun;17(3):313-8. doi: 10.1007/s11307-014-0795-3.
Mol Imaging Biol. 2015.
PMID: 25319765
Item in Clipboard
Comparison of 68Ga-DOTATOC biodistribution in patients with and without spleenectomy.
Kratochwil C, Mavriopoulou E, Rath D, Afshar-Oromieh A, Apostolopoulos D, Haufe S, Mier W, Haberkorn U, Giesel FL.
Kratochwil C, et al. Among authors: mavriopoulou e.
Q J Nucl Med Mol Imaging. 2015 Mar;59(1):116-20. Epub 2013 Dec 17.
Q J Nucl Med Mol Imaging. 2015.
PMID: 24382404
Item in Clipboard
Cite
Cite